
Curada democratises The Sinclair Method (78–93% success rate validated in over 120 clinical studies) for alcohol reduction through an AI-powered platform. We enable public healthcare systems and clinics to deliver this breakthrough protocol digitally, making evidence-based treatment accessible at scale.

Curada democratises The Sinclair Method (78–93% success rate validated in over 120 clinical studies) for alcohol reduction through an AI-powered platform. We enable public healthcare systems and clinics to deliver this breakthrough protocol digitally, making evidence-based treatment accessible at scale.
What they do: AI-powered digital delivery of The Sinclair Method for alcohol reduction
Headquarters: London, England, United Kingdom
Founded: 2023
Stage / funding: Pre-Seed (Oct 2023); Techstars listed as investor
Team size (approx.): 2 employees
Alcohol reduction / addiction treatment delivered digitally
2023
Digital health
Pre-Seed round announced Oct 11, 2023; total amount for the round not publicly disclosed.
“Techstars participated as an investor in the Pre-Seed round”